1 / 16

Myeloma and the Kidney

Myeloma and the Kidney. Ryan Sanford 2.22.2010. How Often is the Kidney Involved. Symptomatic MM: CRAB hyperCalcemia Renal dysfunction Anemia Bone lesions 1/5 to 2/5 patients with MM have renal involvement. What Does it Signify?. At presentation SCr < 1.5  80% alive at 1 year

trixie
Download Presentation

Myeloma and the Kidney

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Myeloma and the Kidney Ryan Sanford 2.22.2010

  2. How Often is the Kidney Involved • Symptomatic MM: CRAB • hyperCalcemia • Renal dysfunction • Anemia • Bone lesions • 1/5 to 2/5 patients with MM have renal involvement

  3. What Does it Signify? • At presentation • SCr < 1.5  80% alive at 1 year • SCr > 2.3  50% alive at 1 year • Renal Improvement to MM Treatment also favorable

  4. The Immunoglobulin • Light Chains come in lambda and kappa

  5. A Few General Points First • The Proteins of MM • Light chains (LC) almost always the problem • Various potential proteins to be produced • Intact immunoglobulins • +/- Light Chains and Heavy Chains • The SPEP: • Not a good test to identify LCs • Increased sensitivity if coupled with serum immunofixation • Can only quantify LCs with direct assessment • The UPEP • Prior to serum free light chain assessment, the UPEP was the test of choice to find LCs

  6. The Light Chain (LC) • aka Bence Jones proteins • Monoclonal • A ratio of κ:λ • Freely filtered, absorbed in PCT • The LC biochemical properties determines the type, if any, of renal disease

  7. The Serum Free Light Chain Assessment • Polyclonal ABs directed at hidden LC epitopes (when a full Ig) used for sensitive quantification of κ and λ light chains • Coupled with SPEP more Sn/Sp than SPEP/UPEP • Could be replacing UPEP as test of choice

  8. What Types of Involvement • Light chain cast nephropathy – Myeloma Kidney [>40% of cases] • Light chain deposition disease [<10%] • Primary AL Amyloidosis [<10%] • Also: Hypercalcemia, interstitial nephritis, acquired Fanconi’s syndrome, GN

  9. Proteinuria in MM • Albuminuria [a grossly positive U/a for protein] • If positive: • Nonspecfic glomerular leak, nephrosis • LCDD or Amyloidosis • If negative: other proteins or no protein in urine; • cast nephropathy • Addition of Sulfosalicylic Acid to Supernatant • If bland sediment and minimal protein on U/a • Precipitates all urinary protein • If positive suggestive of light chains in urine

  10. Cast Nephropathy / Myeloma Kidney • Acute or Chronic • Worsened by volume depletion • Two mechanisms • Intratubular casts and obstruction • LC has affinity for Tamm-Horsfall protein (secreted in thick AL) • See casts in distal nephron • Direct tubular toxicity • U/a: trace/no protein; bland sediment

  11. With the Microscope LC Cast with Obstruction

  12. Treatment of Cast Nephropathy • Chemotherapy to reduce LC production • Aggressive hydration • Plasmapheresis? • Rapid removal of toxic LC • Contentious • If beneficial – best for those with high levels of LCs, severe renal failure, and firm diagnosis of cast nephropathy

  13. AL Amyloidosis • LC uptake, processing, and secretion by macrophages • Secretion product precipitates into β-pleated fibrils, becoming Congophilic • Nephrosis and progressive loss of GFR

  14. Light Chain Deposition Disease • Similar to AL Amyloidosis, except no fibril formation of Congophilic staining • Nephrosis and progressive loss of GFR

  15. Tubular Malfunction • LCs reabsorbed in PCT and accumulate • Fanconi Syndrome • Phosphate wasting • Proximal RTA [type 2] • Hypouricemia • Glycosuria • Proteinuria • Hypokalemia and hypochloremia

  16. References • UpToDate.com • Hutchison, C.A. et al. Nat Rev Nephrol. Serum free light chain assessment in monoclonal gammopathy and kidney disease. 5, 621-627 (2009)

More Related